These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9678531)

  • 1. Increased levels but preserved diurnal variation of serum leptin in GH-deficient patients: lack of impact of different modes of GH administration.
    Nørrelund H; Gravholt CH; Englaro P; Blum WF; Rascher W; Chistiansen JS; Jørgensen JO
    Eur J Endocrinol; 1998 Jun; 138(6):644-52. PubMed ID: 9678531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous infusion versus daily injections of growth hormone (GH) for 4 weeks in GH-deficient patients.
    Laursen T; Jørgensen JO; Jakobsen G; Hansen BL; Christiansen JS
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2410-8. PubMed ID: 7543114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evening versus morning injections of growth hormone (GH) in GH-deficient patients: effects on 24-hour patterns of circulating hormones and metabolites.
    Jørgensen JO; Møller N; Lauritzen T; Alberti KG; Orskov H; Christiansen JS
    J Clin Endocrinol Metab; 1990 Jan; 70(1):207-14. PubMed ID: 2294131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic effects of growth hormone administered subcutaneously once or twice daily to growth hormone deficient adults.
    Laursen T; Jørgensen JO; Christiansen JS
    Clin Endocrinol (Oxf); 1994 Sep; 41(3):337-43. PubMed ID: 7525120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioavailability and bioactivity of three different doses of nasal growth hormone (GH) administered to GH-deficient patients: comparison with intravenous and subcutaneous administration.
    Laursen T; Grandjean B; Jørgensen JO; Christiansen JS
    Eur J Endocrinol; 1996 Sep; 135(3):309-15. PubMed ID: 8890721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulsatile versus continuous intravenous administration of growth hormone (GH) in GH-deficient patients: effects on circulating insulin-like growth factor-I and metabolic indices.
    Jørgensen JO; Møller N; Lauritzen T; Christiansen JS
    J Clin Endocrinol Metab; 1990 Jun; 70(6):1616-23. PubMed ID: 2189886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circadian and ultradian rhythm and leptin pulsatility in adult GH deficiency: effects of GH replacement.
    Ahmad AM; Guzder R; Wallace AM; Thomas J; Fraser WD; Vora JP
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3499-506. PubMed ID: 11502770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temporal patterns of circulating leptin levels in lean and obese adolescents: relationships to insulin, growth hormone, and free fatty acids rhythmicity.
    Heptulla R; Smitten A; Teague B; Tamborlane WV; Ma YZ; Caprio S
    J Clin Endocrinol Metab; 2001 Jan; 86(1):90-6. PubMed ID: 11231983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circadian variation in the pharmacokinetics of steady state continuous subcutaneous infusion of growth hormone in adult growth hormone deficient patients.
    Janukonyté J; Parkner T; Lauritzen T; Christiansen JS; Laursen T
    Growth Horm IGF Res; 2013 Dec; 23(6):256-60. PubMed ID: 24094495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different effects of continuous and intermittent patterns of growth hormone administration on lipoprotein levels in growth hormone-deficient patients.
    Laursen T; Lemming L; Jørgensen JO; Klausen IC; Christiansen JS
    Horm Res; 1998; 50(5):284-91. PubMed ID: 9873197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum leptin is increased in growth hormone-deficient adults: relationship to body composition and effects of placebo-controlled growth hormone therapy for 1 year.
    Fisker S; Vahl N; Hansen TB; Jørgensen JO; Hagen C; Orskov H; Christiansen JS
    Metabolism; 1997 Jul; 46(7):812-7. PubMed ID: 9225837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leptin levels in protracted critical illness: effects of growth hormone-secretagogues and thyrotropin-releasing hormone.
    Van den Berghe G; Wouters P; Carlsson L; Baxter RC; Bouillon R; Bowers CY
    J Clin Endocrinol Metab; 1998 Sep; 83(9):3062-70. PubMed ID: 9745404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circadian variation in serum free and total insulin-like growth factor (IGF)-I and IGF-II in untreated and treated acromegaly and growth hormone deficiency.
    Skjaerbaek C; Frystyk J; Kaal A; Laursen T; Møller J; Weeke J; Jørgensen JO; Sandahl Christiansen J; Orskov H
    Clin Endocrinol (Oxf); 2000 Jan; 52(1):25-33. PubMed ID: 10651750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diurnal variation in serum insulin-like growth factor (IGF)-I and IGF binding protein-3 concentrations during daily subcutaneous injections of recombinant human growth hormone in GH-deficient adults.
    Oscarsson J; Johannsson G; Johansson JO; Lundberg PA; Lindstedt G; Bengtsson BA
    Clin Endocrinol (Oxf); 1997 Jan; 46(1):63-8. PubMed ID: 9059559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of moderate interval exercise versus supine rest on the pharmacokinetics and pharmacodynamic profiles of subcutaneously administered growth hormone in adult growth hormone deficient patients.
    Janukonytė J; Parkner T; Lauritzen T; Christiansen JS; Frystyk J; Pedersen HS; Laursen T
    Growth Horm IGF Res; 2014 Oct; 24(5):198-204. PubMed ID: 25037883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of growth hormone and prednisolone on energy metabolism and leptin levels in humans.
    Wolthers T; Grøfte T; Nørrelund H; Poulsen PL; Andreasen F; Christiansen JS; Jørgensen JO
    Metabolism; 1998 Jan; 47(1):83-8. PubMed ID: 9440482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioavailability and bioactivity of intravenous vs subcutaneous infusion of growth hormone in GH-deficient patients.
    Laursen T; Møller J; Jørgensen JO; Orskov H; Christiansen JS
    Clin Endocrinol (Oxf); 1996 Sep; 45(3):333-9. PubMed ID: 8949572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gender variation in leptin circadian rhythm and pulsatility in adult growth hormone deficiency: effects of growth hormone replacement.
    White HD; Ahmad AM; Guzder R; Wallace AM; Fraser WD; Vora JP
    Clin Endocrinol (Oxf); 2003 Apr; 58(4):482-8. PubMed ID: 12641632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unequal impact of age, percentage body fat, and serum testosterone concentrations on the somatotrophic, IGF-I, and IGF-binding protein responses to a three-day intravenous growth hormone-releasing hormone pulsatile infusion in men.
    Iranmanesh A; South S; Liem AY; Clemmons D; Thorner MO; Weltman A; Veldhuis JD
    Eur J Endocrinol; 1998 Jul; 139(1):59-71. PubMed ID: 9703380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term changes in serum insulin-like growth factors (IGF) and IGF binding protein 3 after different modes of intravenous growth hormone (GH) exposure in GH-deficient patients.
    Jørgensen JO; Blum WF; Møller N; Ranke MB; Christiansen JS
    J Clin Endocrinol Metab; 1991 Mar; 72(3):582-7. PubMed ID: 1705258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.